{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T13:51:21Z","timestamp":1782654681427,"version":"3.54.5"},"reference-count":35,"publisher":"American Diabetes Association","issue":"9","license":[{"start":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T00:00:00Z","timestamp":1629936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/content\/license"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,9,1]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>We aimed to test whether type 2 diabetes (T2D)\u2013associated TCF7L2 genetic variants affect insulin sensitivity or secretion in autoantibody-positive relatives at risk for type 1 diabetes (T1D).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                    <jats:p>We studied autoantibody-positive TrialNet Pathway to Prevention study participants (N = 1,061) (mean age 16.3 years) with TCF7L2 single nucleotide polymorphism (SNP) information and baseline oral glucose tolerance test (OGTT) to calculate indices of insulin sensitivity and secretion. With Bonferroni correction for multiple comparisons, P values &amp;lt; 0.0086 were considered statistically significant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>None, one, and two T2D-linked TCF7L2 alleles were present in 48.1%, 43.9%, and 8.0% of the participants, respectively. Insulin sensitivity (as reflected by 1\/fasting insulin [1\/IF]) decreased with increasing BMI z score and was lower in Hispanics. Insulin secretion (as measured by 30-min C-peptide index) positively correlated with age and BMI z score. Oral disposition index was negatively correlated with age, BMI z score, and Hispanic ethnicity. None of the indices were associated with TCF7L2 SNPs. In multivariable analysis models with age, BMI z score, ethnicity, sex, and TCF7L2 alleles as independent variables, C-peptide index increased with age, while BMI z score was associated with higher insulin secretion (C-peptide index), lower insulin sensitivity (1\/IF), and lower disposition index; there was no significant effect of TCF7L2 SNPs on any of these indices. When restricting the analyses to participants with a normal OGTT (n = 743; 70%), the results were similar.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>In nondiabetic autoantibody-positive individuals, TCF7L2 SNPs were not related to insulin sensitivity or secretion indices after accounting for BMI z score, age, sex, and ethnicity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2337\/dc21-0531","type":"journal-article","created":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T16:35:19Z","timestamp":1627576519000},"page":"2039-2044","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":3,"title":["<i>TCF7L2<\/i>\n                    Genetic Variants Do Not Influence Insulin Sensitivity or Secretion Indices in Autoantibody-Positive Individuals at Risk for Type 1 Diabetes"],"prefix":"10.2337","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5871-4645","authenticated-orcid":false,"given":"Maria J.","family":"Redondo","sequence":"first","affiliation":[{"name":"Texas Children\u2019s Hospital, Baylor College of Medicine, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan V.","family":"Warnock","sequence":"additional","affiliation":[{"name":"University of South Florida, Tampa, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid M.","family":"Libman","sequence":"additional","affiliation":[{"name":"University of Pittsburgh, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"Bocchino","sequence":"additional","affiliation":[{"name":"University of South Florida, Tampa, FL"},{"name":"Jaeb Center for Health Research, Tampa, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Cuthbertson","sequence":"additional","affiliation":[{"name":"University of South Florida, Tampa, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Geyer","sequence":"additional","affiliation":[{"name":"University of South Florida, Tampa, FL"},{"name":"Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Pugliese","sequence":"additional","affiliation":[{"name":"University of Miami, Miami, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea K.","family":"Steck","sequence":"additional","affiliation":[{"name":"Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmella","family":"Evans-Molina","sequence":"additional","affiliation":[{"name":"Center for Diabetes and Metabolic Diseases, Indiana University School of Medicine, Indianapolis, IN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothy","family":"Becker","sequence":"additional","affiliation":[{"name":"University of Pittsburgh, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay M.","family":"Sosenko","sequence":"additional","affiliation":[{"name":"Diabetes Research Institute, Miller School of Medicine, University of Miami, Miami, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fida","family":"Bacha","sequence":"additional","affiliation":[{"name":"Texas Children\u2019s Hospital, Baylor College of Medicine, Houston, TX"},{"name":"Children\u2019s Nutrition Research Center, Agricultural Research Service, U.S. Department of Agriculture, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Type 1 Diabetes TrialNet Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2021,8,26]]},"reference":[{"key":"2022031309551867400_B1","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/ng1732","article-title":"Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes","volume":"38","author":"Grant","year":"2006","journal-title":"Nat Genet"},{"key":"2022031309551867400_B2","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1038\/s41588-018-0241-6","article-title":"Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps","volume":"50","author":"Mahajan","year":"2018","journal-title":"Nat Genet"},{"key":"2022031309551867400_B3","doi-asserted-by":"crossref","first-page":"E389","DOI":"10.1210\/jc.2010-1677","article-title":"Variants and haplotypes of TCF7L2 are associated with \u03b2-cell function in patients with newly diagnosed type 2 diabetes: the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 1","volume":"96","author":"Bonetti","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031309551867400_B4","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2337\/db15-1233","article-title":"TCF7L2 genotype and \u03b1-cell function in humans without diabetes","volume":"65","author":"Shah","year":"2016","journal-title":"Diabetes"},{"key":"2022031309551867400_B5","doi-asserted-by":"crossref","first-page":"e136136","DOI":"10.1172\/jci.insight.136136","article-title":"Diabetes-associated genetic variation in TCF7L2 alters pulsatile insulin secretion in humans","volume":"5","author":"Laurenti","year":"2020","journal-title":"JCI Insight"},{"key":"2022031309551867400_B6","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2337\/dc17-0961","article-title":"TCF7L2 genetic variants contribute to phenotypic heterogeneity of type 1 diabetes","volume":"41","author":"Redondo","year":"2018","journal-title":"Diabetes Care"},{"key":"2022031309551867400_B7","doi-asserted-by":"crossref","first-page":"e000008","DOI":"10.1136\/bmjdrc-2013-000008","article-title":"Association of TCF7L2 variation with single islet autoantibody expression in children with type 1 diabetes","volume":"2","author":"Redondo","year":"2014","journal-title":"BMJ Open Diabetes Res Care"},{"key":"2022031309551867400_B8","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/dme.13123","article-title":"Dissecting heterogeneity in paediatric type 1 diabetes: association of TCF7L2 rs7903146 TT and low-risk human leukocyte antigen (HLA) genotypes","volume":"34","author":"Redondo","year":"2017","journal-title":"Diabet Med"},{"key":"2022031309551867400_B9","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1034\/j.1399-5448.2003.00012.x","article-title":"Coexistence of type 1 and type 2 diabetes mellitus: \u201cdouble\u201d diabetes?","volume":"4","author":"Libman","year":"2003","journal-title":"Pediatr Diabetes"},{"key":"2022031309551867400_B10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1196\/annals.1447.054","article-title":"Type 1 Diabetes TrialNet\u2014an international collaborative clinical trials network","volume":"1150","author":"Skyler","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"2022031309551867400_B11","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1399-5448.2008.00464.x","article-title":"The TrialNet Natural History Study of the Development of Type 1 Diabetes: objectives, design, and initial results","volume":"10","author":"Mahon","year":"2009","journal-title":"Pediatr Diabetes"},{"key":"2022031309551867400_B12","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.2337\/dc16-0302","article-title":"Do electrochemiluminescence assays improve prediction of time to type 1 diabetes in autoantibody-positive TrialNet subjects?","volume":"39","author":"Fouts","year":"2016","journal-title":"Diabetes Care"},{"key":"2022031309551867400_B13","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1373\/clinchem.2007.101287","article-title":"Standardization of C-peptide measurements","volume":"54","author":"Little","year":"2008","journal-title":"Clin Chem"},{"key":"2022031309551867400_B14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jpeds.2003.09.045","article-title":"Validation of surrogate estimates of insulin sensitivity and insulin secretion in children and adolescents","volume":"144","author":"Gungor","year":"2004","journal-title":"J Pediatr"},{"key":"2022031309551867400_B15","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jpeds.2007.11.044","article-title":"Measures of beta-cell function during the oral glucose tolerance test, liquid mixed-meal test, and hyperglycemic clamp test","volume":"152","author":"Bacha","year":"2008","journal-title":"J Pediatr"},{"key":"2022031309551867400_B16","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1399-5448.2011.00841.x","article-title":"Determinants of glycemic control in youth with type 2 diabetes at randomization in the TODAY study","volume":"13","author":"Bacha","year":"2012","journal-title":"Pediatr Diabetes"},{"key":"2022031309551867400_B17","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1210\/jc.2010-2813","article-title":"Surrogate estimates of insulin sensitivity in obese youth along the spectrum of glucose tolerance from normal to prediabetes to diabetes","volume":"96","author":"George","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031309551867400_B18","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.2337\/dc06-2389","article-title":"Role of insulin resistance in predicting progression to type 1 diabetes","volume":"30","author":"Xu","year":"2007","journal-title":"Diabetes Care"},{"key":"2022031309551867400_B19","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2337\/dc16-0455","article-title":"Adiponectin, insulin sensitivity, \u03b2-cell function, and racial\/ethnic disparity in treatment failure rates in TODAY","volume":"40","author":"Arslanian","year":"2017","journal-title":"Diabetes Care"},{"key":"2022031309551867400_B20","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"2022031309551867400_B21","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.jpeds.2012.11.037","article-title":"Indices of insulin secretion during a liquid mixed-meal test in obese youth with diabetes","volume":"162","author":"Bacha","year":"2013","journal-title":"J Pediatr"},{"key":"2022031309551867400_B22","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2337\/dc08-1478","article-title":"Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels","volume":"32","author":"Utzschneider","year":"2009","journal-title":"Diabetes Care"},{"key":"2022031309551867400_B23","doi-asserted-by":"crossref","first-page":"107589","DOI":"10.1016\/j.jdiacomp.2020.107589","article-title":"Linearization of the Disposition Index equation allows evaluation of secretion-sensitivity coupling slopes","volume":"34","author":"Mather","year":"2020","journal-title":"J Diabetes Complications"},{"key":"2022031309551867400_B24","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.2337\/dc12-2393","article-title":"Effects of metformin, metformin plus rosiglitazone, and metformin plus lifestyle on insulin sensitivity and \u03b2-cell function in TODAY","volume":"36","author":"TODAY Study Group","year":"2013","journal-title":"Diabetes Care"},{"key":"2022031309551867400_B25","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1172\/JCI30706","article-title":"Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes","volume":"117","author":"Lyssenko","year":"2007","journal-title":"J Clin Invest"},{"key":"2022031309551867400_B26","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2337\/db09-1169","article-title":"TCF7L2 variant rs7903146 affects the risk of type 2 diabetes by modulating incretin action","volume":"59","author":"Villareal","year":"2010","journal-title":"Diabetes"},{"key":"2022031309551867400_B27","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.2337\/dc20-0445","article-title":"A reduced incretin effect mediated by the rs7903146 variant in the TCF7L2 gene is an early marker of \u03b2-cell dysfunction in obese youth","volume":"43","author":"Galderisi","year":"2020","journal-title":"Diabetes Care"},{"key":"2022031309551867400_B28","doi-asserted-by":"crossref","first-page":"470","DOI":"10.2337\/diabetes.50.2.470","article-title":"Type I diabetes manifested solely by 2-h oral glucose tolerance test criteria","volume":"50","author":"Greenbaum","year":"2001","journal-title":"Diabetes"},{"key":"2022031309551867400_B29","doi-asserted-by":"crossref","first-page":"951","DOI":"10.2337\/diabetes.51.4.951","article-title":"Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose","volume":"51","author":"Greenbaum","year":"2002","journal-title":"Diabetes"},{"key":"2022031309551867400_B30","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.2337\/dc19-2288","article-title":"C-peptide levels in subjects followed longitudinally before and after type 1 diabetes diagnosis in TrialNet","volume":"43","author":"Bogun","year":"2020","journal-title":"Diabetes Care"},{"key":"2022031309551867400_B31","doi-asserted-by":"crossref","first-page":"e120877","DOI":"10.1172\/jci.insight.120877","article-title":"\u03b2 Cell dysfunction exists more than 5 years before type 1 diabetes diagnosis","volume":"3","author":"Evans-Molina","year":"2018","journal-title":"JCI Insight"},{"key":"2022031309551867400_B32","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ajhg.2011.12.022","article-title":"Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci [published correction appears in Am J Hum Genet. 2012;90(4):753]","volume":"90","author":"Saxena","year":"2012","journal-title":"Am J Hum Genet"},{"key":"2022031309551867400_B33","doi-asserted-by":"crossref","first-page":"4815","DOI":"10.1210\/jc.2019-00183","article-title":"Interaction between overweight and genotypes of HLA, TCF7L2, and FTO in relation to the risk of latent autoimmune diabetes in adults and type 2 diabetes","volume":"104","author":"Hjort","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031309551867400_B34","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.2337\/dc10-0802","article-title":"Prognostic performance of metabolic indexes in predicting onset of type 1 diabetes","volume":"33","author":"Xu","year":"2010","journal-title":"Diabetes Care"},{"key":"2022031309551867400_B35","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jpeds.2011.12.050","article-title":"Oral disposition index in obese youth from normal to prediabetes to diabetes: relationship to clamp disposition index","volume":"161","author":"Sjaarda","year":"2012","journal-title":"J Pediatr"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/44\/9\/2039\/633181\/dc210531.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/44\/9\/2039\/633181\/dc210531.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,13]],"date-time":"2022-03-13T07:05:06Z","timestamp":1647155106000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/44\/9\/2039\/138837\/TCF7L2-Genetic-Variants-Do-Not-Influence-Insulin"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,26]]},"references-count":35,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,8,26]]},"published-print":{"date-parts":[[2021,9,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc21-0531","relation":{"has-preprint":[{"id-type":"doi","id":"10.2337\/figshare.14770083","asserted-by":"object"},{"id-type":"doi","id":"10.2337\/figshare.14770083.v2","asserted-by":"object"}]},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,26]]}}}